Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
Long T Phan,1,2 Geoffrey K Broadhead,1,3 Thomas H Hong,1 Andrew A Chang1,3 1Sydney Retina, Sydney, New South Wales, Australia; 2Discipline of Orthoptics, University of Technology Sydney, Sydney, New South Wales, Australia; 3Save Sight Institute, The University of Sydney, Sydney, New South Wales, Aus...
Guardado en:
Autores principales: | Phan LT, Broadhead GK, Hong TH, Chang AA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc9a5bd4700045f3a39888f0f967a671 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The burden of neovascular age-related macular degeneration: a patient’s perspective
por: Spooner KL, et al.
Publicado: (2018) -
Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
por: Kaya A
Publicado: (2016) -
Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou SA, et al.
Publicado: (2017) -
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
por: Spooner K, et al.
Publicado: (2017) -
Visual acuity loss associated with excessive “dry macula” in exudative age-related macular degeneration
por: Takahashi H, et al.
Publicado: (2018)